bytevyte
bytevyte
Language
EN DE ES FR PT IT
Follow
quick-beats —

China Approves NEO Brain-Computer Implant for Commercial Use in Paralysis Patients

NEO brain-computer implant

Neuracle Medical Technology has secured commercial approval for its NEO brain-computer implant, making it the first invasive neural interface cleared for general medical use. The authorization from China's National Medical Products Administration (NMPA) on June 8, 2026, allows the device to move beyond clinical trials and into the consumer healthcare market for patients with severe paralysis.

The NEO brain-computer implant is a wireless, coin-sized device designed to help individuals with spinal cord injuries or conditions like ALS regain independence. Unlike many experimental neural links that require wires protruding from the skull, the NEO system uses an external magnetic coil to transmit both power and data. This design choice removes the need for an internal battery, potentially extending the lifespan of the hardware while reducing the frequency of replacement surgeries.

Advanced Non-Penetrating Technology

A key technical distinction of the NEO system is its approach to neural contact. The device features eight electrodes that rest on the surface of the brain rather than penetrating the delicate neural tissue. Neuracle Medical Technology developed this non-invasive electrode array in collaboration with Tsinghua University to minimize the risk of long-term inflammation and scarring, which are common hurdles for penetrating implants.

Clinical results leading up to the NMPA approval demonstrated the practical utility of the NEO brain-computer implant. In one trial, a tetraplegic patient successfully used the interface to operate a soft pneumatic glove. By translating brain signals into digital commands, the patient was able to grasp and move objects, a significant milestone for restoring motor function through technology.

The commercial rollout of the NEO system is a shift in the brain-computer interface market from laboratory research to accessible medical hardware. While initial availability will focus on clinical settings for paralysis patients, the approval establishes a regulatory framework for future neural consumer devices. Neuracle Medical Technology has not yet disclosed the final retail pricing for the procedure and hardware.

While we strive for accuracy, bytevyte can make mistakes. Users are advised to verify all information independently. We accept no liability for errors or omissions.

AI-generated image.

✔Human Verified

Share